Physician profile
Patrick Scott Edwards
NPI 1225004575
$883.90
in general payments reported to CMS, 2019-2025
13 companies · $155 in 2025
The $155 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $11.16 · 2021: $92.49 · 2022: $146 · 2023: $45.53 · 2024: $215 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $207.52 | 2024-2025 | Qelbree |
| Tris Pharma INC | $188.57 | 2019-2025 | Onyda Xr, Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $120.16 | 2019-2022 | |
| Corium, LLC | $58.46 | 2024-2025 | Azstarys |
| Sobi, INC | $55.45 | 2019-2023 | |
| Glaxosmithkline, LLC. | $53.11 | 2019-2022 | |
| Sanofi Pasteur INC. | $50.76 | 2019-2025 | |
| Neos Therapeutics, Lp | $32.08 | 2019 | |
| Ironshore Pharmaceuticals INC. | $30.19 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.83 | 2022 | |
| Pfizer INC. | $27.87 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $16.96 | 2023 | Gardasil 9, Vaxelis, Proquad |
| Astrazeneca Pharmaceuticals Lp | $12.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.